REDWOOD CITY, CA--(Marketwire - October 24, 2008) - PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it will release its financial results for the third quarter 2008 following the close of the U.S. financial markets on Thursday, November 6, 2008. Following the release, PDL will hold a conference call at 4:30 p.m. Eastern time to discuss these financial results and provide an update on company activities. Faheem Hasnain, president and CEO, Mark McCamish, M.D., Ph.D., senior vice president and CMO, and Andrew Guggenhime, senior vice president and CFO, will conduct the call.
